Redpoint Investment Management Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History

Redpoint Investment Management Pty LTD

$684 Million
Q3 2022

A detailed history of Redpoint Investment Management Pty LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Redpoint Investment Management Pty LTD holds 2,549 shares of REGN stock, worth $1.93 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,549

Previous 3,123 18.38%

Holding current value

$1.93 Million

Previous $1.85 Million 4.88%

% of portfolio

0.26%

Previous 0.22%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$573.97 - $724.32 $329,458 - $415,759	-574 Reduced 18.38%	2,549 $1.76 Million
Q1 2022 Apr 13, 2022	SELL	$595.12 - $698.43 $28,565 - $33,524	-48 Reduced 1.51%	3,123 $2.18 Million
Q4 2021 Jan 19, 2022	BUY	$543.48 - $670.97 $59,782 - $73,806	110 Added 3.59%	3,171 $2 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $107,917 - $128,020	-188 Reduced 5.79%	3,061 $1.85 Million
Q2 2021 Aug 05, 2021	SELL	$472.8 - $558.54 $124,819 - $147,454	-264 Reduced 7.51%	3,249 $1.82 Million
Q1 2021 Apr 13, 2021	BUY	$446.73 - $548.2 $89,346 - $109,640	200 Added 6.04%	3,513 $1.66 Million
Q4 2020 Jan 13, 2021	BUY	$478.3 - $607.98 $373,552 - $474,832	781 Added 30.85%	3,313 $1.6 Million
Q3 2020 Oct 09, 2020	SELL	$544.75 - $658.21 $1.76 Million - $2.13 Million	-3,230 Reduced 56.06%	2,532 $1.42 Million
Q2 2020 Jul 17, 2020	SELL	$493.32 - $643.92 $163,782 - $213,781	-332 Reduced 5.45%	5,762 $3.59 Million
Q2 2019 Aug 07, 2019	SELL	$299.6 - $414.82 $263,348 - $364,626	-879 Reduced 12.61%	6,094 $1.91 Million
Q1 2019 May 14, 2019	BUY	$372.08 - $439.57 $490,029 - $578,913	1,317 Added 23.29%	6,973 $2.86 Million
Q4 2017 Aug 09, 2018	BUY	$358.63 - $469.95 $2.03 Million - $2.66 Million	5,656	5,656 $2.13 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.

Account

Redpoint Investment Management Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History